Zeria Pharmaceutical Co., Ltd. 4559.T Stock
Zeria Pharmaceutical Co., Ltd. Price Chart
Zeria Pharmaceutical Co., Ltd. 4559.T Financial and Trading Overview
Zeria Pharmaceutical Co., Ltd. stock price | 2076 JPY |
Previous Close | 2483 JPY |
Open | 2490 JPY |
Bid | 2548 JPY x 0 |
Ask | 2556 JPY x 0 |
Day's Range | 2488 - 2577 JPY |
52 Week Range | 1984 - 2600 JPY |
Volume | 268.9K JPY |
Avg. Volume | 84.5K JPY |
Market Cap | 112.62B JPY |
Beta (5Y Monthly) | 0.097318 |
PE Ratio (TTM) | 18.734417 |
EPS (TTM) | 196.02 JPY |
Forward Dividend & Yield | 44 (1.73%) |
Ex-Dividend Date | September 28, 2023 |
1y Target Est | 2800 JPY |
4559.T Valuation Measures
Enterprise Value | 145.19B JPY |
Trailing P/E | 18.734417 |
Forward P/E | 13.762457 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 1.6469724 |
Price/Book (mrq) | 1.7208041 |
Enterprise Value/Revenue | 2.123 |
Enterprise Value/EBITDA | 9.575 |
Trading Information
Zeria Pharmaceutical Co., Ltd. Stock Price History
Beta (5Y Monthly) | 0.097318 |
52-Week Change | 19.95% |
S&P500 52-Week Change | 20.43% |
52 Week High | 2600 JPY |
52 Week Low | 1984 JPY |
50-Day Moving Average | 2423.06 JPY |
200-Day Moving Average | 2227.47 JPY |
4559.T Share Statistics
Avg. Volume (3 month) | 84.5K JPY |
Avg. Daily Volume (10-Days) | 112.59K JPY |
Shares Outstanding | 44.08M |
Float | 35.73M |
Short Ratio | N/A |
% Held by Insiders | 26.61% |
% Held by Institutions | 23.74% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 40 |
Trailing Annual Dividend Yield | 1.61% |
5 Year Average Dividend Yield | 168.00% |
Payout Ratio | 0.2692 |
Last Split Factor | 1.1:1 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | March 31, 2023 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | March 31, 2024 |
Profitability
Profit Margin | 9.05% |
Operating Margin (ttm) | 13.18% |
Gross Margin | 72.36% |
EBITDA Margin | 22.17% |
Management Effectiveness
Return on Assets (ttm) | 4.34% |
Return on Equity (ttm) | 10.27% |
Income Statement
Revenue (ttm) | 68.38B JPY |
Revenue Per Share (ttm) | 1548.06 JPY |
Quarterly Revenue Growth (yoy) | 15.40% |
Gross Profit (ttm) | N/A |
EBITDA | 15.16B JPY |
Net Income Avi to Common (ttm) | 6.19B JPY |
Diluted EPS (ttm) | 136.38 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 16.22B JPY |
Total Cash Per Share (mrq) | 367.94 JPY |
Total Debt (mrq) | 49.43B JPY |
Total Debt/Equity (mrq) | 75.26 JPY |
Current Ratio (mrq) | 1.022 |
Book Value Per Share (mrq) | 1484.771 |
Cash Flow Statement
Operating Cash Flow (ttm) | 13.16B JPY |
Levered Free Cash Flow (ttm) | 8.81B JPY |
Profile of Zeria Pharmaceutical Co., Ltd.
Country | Japan |
State | N/A |
City | Tokyo |
Address | 10-11 Nihonbashi Kobuna-cho |
ZIP | 103-8351 |
Phone | 81 3 3663 2351 |
Website | https://www.zeria.co.jp |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | N/A |
Zeria Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures, sells, imports, and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural chemicals, industrial chemicals, and reagents in Japan and internationally. It also provides cosmetics, health foods, alcoholic beverages, soft drinks, food additives, livestock feed, hygienic goods, medical devices, health equipment, hygiene facilities and equipment, beauty appliances, and measuring and analytical equipment. The company offers products in the gastrointestinal field, including therapeutic agents for functional dyspepsia, ulcerative colitis, Crohn's disease, and gastritis and ulcers; zinc containing anti-ulcerants; oral bowel cleansing agents; laxatives; therapeutic agents for hypophosphatemia, and iron deficiency anemia; long-acting calcium channel blockers; oral NSAID; anti-leukopenia after radiotherapy products; anti-inflammatory topical blood circulation enhancers; non-steroidal anti-inflammatory ophthalmic solutions; and proton pump inhibitors. It also offers consumer healthcare products, such as nutritional health drugs, remedies for gastrointestinal diseases, western herbal medicines, cold remedies, ophthalmic solutions, anti-inflammatory/analgesics, hemorroidal remedies, dermal remedies, quasi-drugs/cosmetics, nutrient tonics, soft drinks/health foods, and food for specified health uses. The company was formerly known as Zeria Yakusho Kenkyusho Co., Ltd. and changed its name to Zeria Pharmaceutical Co., Ltd. in May 1970. Zeria Pharmaceutical Co., Ltd. was incorporated in 1955 and is headquartered in Tokyo, Japan.
Q&A For Zeria Pharmaceutical Co., Ltd. Stock
What is a current 4559.T stock price?
Zeria Pharmaceutical Co., Ltd. 4559.T stock price today per share is 2076 JPY.
How to purchase Zeria Pharmaceutical Co., Ltd. stock?
You can buy 4559.T shares on the Tokyo exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Zeria Pharmaceutical Co., Ltd.?
The stock symbol or ticker of Zeria Pharmaceutical Co., Ltd. is 4559.T.
Which industry does the Zeria Pharmaceutical Co., Ltd. company belong to?
The Zeria Pharmaceutical Co., Ltd. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Zeria Pharmaceutical Co., Ltd. have in circulation?
The max supply of Zeria Pharmaceutical Co., Ltd. shares is 44.08M.
What is Zeria Pharmaceutical Co., Ltd. Price to Earnings Ratio (PE Ratio)?
Zeria Pharmaceutical Co., Ltd. PE Ratio is 10.59075500 now.
What was Zeria Pharmaceutical Co., Ltd. earnings per share over the trailing 12 months (TTM)?
Zeria Pharmaceutical Co., Ltd. EPS is 196.02 JPY over the trailing 12 months.
Which sector does the Zeria Pharmaceutical Co., Ltd. company belong to?
The Zeria Pharmaceutical Co., Ltd. sector is Healthcare.
Zeria Pharmaceutical Co., Ltd. 4559.T included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
NASDAQ Developed ex US SC NTR G NQDMXUSSCGBPN | 1704.47 GBP 2179.91 USD |
0
|
— — | 1704.47 GBP 2179.91 USD | 1704.47 GBP 2179.91 USD | — - | — — |
- {{ link.label }} {{link}}